Home Illinois Cancer Center at Illinois Scientists Discover New Breast Cancer Treatment

Cancer Center at Illinois Scientists Discover New Breast Cancer Treatment

An estimated 70% of women diagnosed with breast cancer have ER-positive (ER+) breast cancer. Cancer Center at Illinois researchers are leading the science behind a new global licensing agreement between Bayer AG and Systems Oncology for a new breast cancer compound called ERSO. Developed by the laboratories of Paul Hergenrother, chemistry professor, and David Shapiro, biochemistry professor, ERSO has been shown to target breast cancer cells that express the estrogen receptor.

Their research was the first to show that the compound can effectively target and kill certain cancer cells, especially ER+ breast cancer cells. According to Hergenrother, these breast cancer cells are very sensitive to ERSO, which kills the cells rapidly.

“To have a major company, like Bayer, decide to license ERSO speaks volumes about the societal impact Illinois research can have,” said Hergenrother, who is also the deputy director of the Cancer Center at Illinois.

Announcement

[Illinois] Welcome, Back!

Join Diversity & Social Justice Education and the University YMCA in celebrating the start of the Fall semester! Come and learn about...

[Urbana] New music and boating program at the Lake House!

NEW! Crystal Lake Park Candlelight Serenade Export to Calendar Saturday, August 20, 2022

[Urbana] Climate Action Week 2022

August 22-28At Crystal Lake Park This week will be full of engaging opportunities to learn about climate change causes...

[Illinois] Dump & Run call for volunteers

We need volunteers for the BIG SALE on August 20 and 21. Shifts may involve some lifting, and the Pavilion is not...